Bristol Myers Squibb And The New Wave Of Cancer Drugs | Latest News RSS feed

Bristol Myers Squibb And The New Wave Of Cancer Drugs - Latest News


Bristol Myers Squibb And The New Wave Of Cancer Drugs

Even with the best cancer drugs, doctors are forced to switch from one therapy to the next as the tumors rapidly develop resistance. A new wave of immunotherapy drugs, in the spotlight of the upcoming ... read more

Bristol-Myers Squibb Wins U.S. Approval for Melanoma Drug

Bristol-Myers Squibb ... beginning of a new wave of treatments that spur the immune system against cancer. Bristol-Myers will be combining Yervoy with other treatments in trials to improve its ... read more

FDA approves new Bristol-Myers treatment for multiple myeloma

(Reuters) - The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for ... leader among drugmakers racing to develop a new ... read more

Looking for another news?


Cancer Drugs: Getting Close And Personal

Now, however, that crudeness is rapidly giving way to sophistication, as a new wave ... to treating cancer is to rally the immune system to join the fight. Ipilimumab, a drug to treat melanoma, was ... read more


Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave

In the world of cancer drugs, calling a ... and Eli Lilly ($LLY) and Bristol-Myers Squibb's ($BMY) Erbitux--at least so far. After a period of less-than-impressive growth from new launches from 2005 ... read more

Bristol cancer, clot drugs drive profit beat, shares rise

(Reuters) - Bristol ... oncology drug, hepatitis C treatments and its Eliquis blood clot preventer. Company shares rose 1.9 percent in premarket trading.Bristol-Myers is considered the leader among ... read more

UPDATED: Bristol-Myers' pioneering PD-1 drug Opdivo OK'd by FDA for melanoma

Bristol-Myers Squibb ($BMY) has won a pioneering FDA ... and AstraZeneca ($AZN), represent the cutting edge of a new wave of drugs that can finally start to unleash a major immune response to cancer ... read more

Investor Sues Over Bristol-Myers' $74B Deal to Buy Cancer Drug Maker

An investor in Celgene Corp. on Monday sued over Bristol-Myers Squibb ... the three drugs at $6.3 billion—far below the $40 to $50 billion the firm claimed they would be worth over five years. Because ... read more

Bristol's drug pricing under fire as UK agency rejects Opdivo

LONDON (Reuters) - Bristol-Myers Squibb's closely watched new drug Opdivo, one of the first of a new wave of cancer medicines that boost the immune system, has been rejected as too expensive for ... read more

Bristol cancer, clot drugs drive profit beat, shares rise

Oct 27 (Reuters) - Bristol-Myers Squibb ... drug, hepatitis C treatments and its Eliquis blood clot preventer. Company shares rose 1.9 percent in premarket trading. Bristol-Myers is considered the ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us